Don't have an account?
Learn More -or- Register Now
Are you an expert on what it takes to generate income once your regular paycheck stops? Take this quick test to find out.
Take the TestSpryng is a new crowdfunding tool for college savings where you create a personalized profile and share it with friends and family.
Learn moreOpen popular accounts online:
Don't have an account?
Learn More -or- Register Now
Conflicting headlines and market turmoil leave questions explored in this Global Macro Shifts.
Templeton Global Macro®
China has cemented itself as an economic powerhouse fueled by rapid growth and social development. Already the world's second-largest economy, the nation's influence is undeniable. But conflicting headlines and recent market turmoil are leaving investors with big questions about the future. Dr. Michael Hasenstab, Chief Investment Officer, Templeton Global Macro offers an in-depth look at the challenges and opportunities China faces as it continues to grow.
The government has long played an influential role in China's economic rise. But Dr. Hasenstab says key reforms and innovation have the private sector becoming increasingly more important.
The US, Eurozone and Japan are each telling very different economic stories. Dr. Michael Hasenstab breaks down the latest data and offers insights about where these regions are headed.
What makes the world's second largest economy tick? Dr. Michael Hasenstab delivers timely insights to help you put the news headlines about China into context.
The US Economy is showing signs of picking up steam; Greece continues to cloud the recovery in the Eurozone; and Japan is making progress on reforms, but is it enough to boost growth? Dr. Michael Hasenstab examines these developments and the divergent roles of monetary policy in each region.
For more on Divergent Monetary Policy, click here.
China has reached a crucial stage in its economic evolution. Dr. Michael Hasenstab says while the country's transformation poses challenges, there are still reasons for optimism about China's prospects.
China's economic transformation doesn't come without challenges. Dr. Michael Hasenstab takes a closer look at the role of monetary policy, potential debt risks and the impact of the recent equity market turmoil.
China's population has long had a profound impact on the country's story. Dr. Michael Hasenstab examines the evolution of China's labor market and the possibility of falling into a middle-income trap.
China's traditional growth sectors have slowed. Find out where new opportunities are emerging to pave the way for a rebalancing in the economy. Dr. Michael Hasenstab takes a closer look at this shift and the new growth engines on the rise.
Michael Hasenstab, Ph.D Portfolio Manager,
Chief Investment Officer,
Templeton Global Macro ®
Sonal Desai, Ph.D. Portfolio Manager,
Director of Research,
Templeton Global Macro ®
Calvin Ho, Ph.D. Deputy Director of Research,
Templeton Global Macro ®
Hyung C. Shin, Ph.D. Senior Global Macro & Research Analyst,
Templeton Global Macro ®
Kang Tan, Ph.D. Senior Global Macro & Research Analyst,
Templeton Global Macro ®
Diego Valderrama, Ph.D. Senior Global Macro & Research Analyst,
Templeton Global Macro ®
Attila Korpos, Ph.D. Senior Global Macro & Research Analyst,
Templeton Global Macro ®
All investments involve risks, including possible loss of principal. Bond prices generally move in the opposite direction of interest rates. Thus, as the prices of bonds in an investment portfolio adjust to a rise in interest rates, the value of the portfolio may decline. Special risks are associated with foreign investing, including currency fluctuations, economic instability and political developments. Investments in developing markets, of which frontier markets are a subset, involve heightened risks related to the same factors, in addition to those associated with these markets' smaller size, lesser liquidity and lack of established legal, political, business and social frameworks to support securities markets.
This material is intended to be of general interest only and should not be construed as individual investment advice or a recommendation or solicitation to buy, sell or hold any security or to adopt any investment strategy. It does not constitute legal or tax advice.
The views expressed are those of the investment manager and the comments, opinions and analyses are rendered as at publication date and may change without notice. The information provided in this material is not intended as a complete analysis of every material fact regarding any country, region or market. All investments involve risks, including possible loss of principal.
Data from third party sources may have been used in the preparation of this material and Franklin Templeton ("FT") has not independently verified, validated or audited such data. FT accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments opinions and analyses in the material is at the sole discretion of the user.
Products, services and information may not be available in all jurisdictions and are offered outside the U.S. by other FT affiliates and/or their distributors as local laws and regulation permits. Please consult your own financial professional or Franklin Templeton institutional contact for further information on availability of products and services in your jurisdiction.
Issued in the U.S. by Franklin Templeton Distributors, Inc., One Franklin Parkway, San Mateo, California 94403-1906, (800) DIAL BEN/342-5236, franklintempleton.com - Franklin Templeton Distributors, Inc. is the principal distributor of Franklin Templeton U.S. registered products, which are not FDIC insured; may lose value; and are not bank guaranteed and are available only in jurisdictions where an offer or solicitation of such products is permitted under applicable laws and regulation.
You need Adobe Acrobat Reader to view and print PDF documents. Download a free version from Adobe's website.
Franklin Templeton Distributors, Inc.
This website is for US residents.
This website is for US residents.
Copyright © 2021 Franklin Templeton. All Rights Reserved.
There are literature items in your cart. If you sign out, all items will be removed.
Click "Stay Signed In" to continue your session and keep items in your cart.
Otherwise, click Sign out to end your session and empty your cart.
You can compare a maximum of 4 funds.
Money funds and liquidated funds cannot be added to comparison.
Quarterly commentary discussing fund performance. View more details
Client Use: | (FINRA Letter) |
---|---|
Literature Code: | |
Format: | () |
Publication Date: | |
Next Update: |